IceCure Medical (ICCM) Gross Margin (2020 - 2026)

IceCure Medical (ICCM) has reported Gross Margin for 7 consecutive years, with 27.89% the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Margin rose 294.0% year-over-year to 27.89% in Q2 2026; TTM through Jun 2026 was 36.1%, a 19.0% increase from a year earlier, with the FY2025 full-year figure at 36.28%, down 781.0% from the prior year.
• Gross Margin was 27.89% for Q2 2026 at IceCure Medical, down from 32.38% in the prior quarter.
• Over five years, Gross Margin peaked at 58.1% in Q1 2022 and troughed at 7.03% in Q3 2023.
• A 5-year average of 37.77% and a median of 40.64% in 2023 frame the typical range for Gross Margin.
• Across the five-year window, Gross Margin plunged 3322 bps in 2023 and surged 4253 bps in 2024, its largest moves.
• Over 5 years, Gross Margin stood at 49.09% in 2022, then fell by 8 bps to 45.34% in 2023, then gained by 5 bps to 47.66% in 2024, then retreated by 2 bps to 46.91% in 2025, then tumbled by 41 bps to 27.89% in 2026.
• The last three Gross Margin figures came in at 27.89% (Q2 2026), 32.38% (Q1 2026), and 46.91% (Q4 2025), per Business Quant data.